Bloomberg Law
Jan. 27, 2020, 8:23 PM

Coronavirus Samples Grown by CDC Coming to Drug Companies Soon

Jeannie Baumann
Jeannie Baumann
Reporter

The CDC is growing samples of the novel coronavirus so researchers can develop medical countermeasures and better understand how the latest SARS-like virus has spread, the agency’s respiratory disease director said.

“We are growing the virus in cell culture, which is necessary for further studies, including the additional genetic characterizations,” Nancy Messonnier, director of the Centers for Disease Control and Prevention’s National Center for Immunization and Respiratory Diseases, said during a Monday telephone press briefing.

Those sample viruses will allow companies like Gilead Sciences Inc. and AbbVie Inc. that are pursuing potential treatments to see if those drugs can work. ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.